Literature DB >> 7095896

Detection of a human melanoma-associated antigen, p97, in histological sections of primary human melanomas.

H J Garrigues, W Tilgen, I Hellstróm, W Franke, K E Hellström.   

Abstract

The unlabelled antibody technique of Sternberger was used to study the localization in histological sections of human melanoma-associated antigen p97, which is defined by a monoclonal antibody. The antigen was detected in 8 of 10 primary skin melanomas, in 6 of 7 metastatic melanomas and in 2 of 2 compound nevi. It was localized at the cell surface, the cytoplasm and the nucleus always being negative. The antigen was not seen in cells from 3 basal cell carcinomas, 1 squamous cell carcinoma, 1 leiomyosarcoma, or in samples of normal skin (including keratinocytes, connective tissue consisting of collagenous and elastic fibers, fibroblasts, sebaceous glands, blood vessels, smooth muscles, or inflammatory cells such as granulocytes, lymphocytes and macrophages), kidney or lung. There was, however, staining of some cells in the secretory segment of eccrine sweat glands from 2 patients, possibly corresponding to myoepithelial cells. Antigen expression was somewhat variable between cells from different melanomas as well as between individual cells from the same melanoma. The possible diagnostic value of this procedure for identification and classification of melanomas is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7095896     DOI: 10.1002/ijc.2910290505

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Monoclonal antibody L6-daunomycin conjugates constructed to release free drug at the lower pH of tumor tissue.

Authors:  E Lavie; D L Hirschberg; G Schreiber; K Thor; L Hill; I Hellstrom; K E Hellstrom
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  A monoclonal antibody specific for cells of the melanocyte lineage.

Authors:  C Vennegoor; P Hageman; H Van Nouhuijs; D J Ruiter; J Calafat; P J Ringens; P Rümke
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

3.  Modulation of melanoma-associated antigens by monoclonal antibodies as visualized by radioimmunoelectron microscopy and radioantibody binding assay.

Authors:  W Tilgen; S Matzku; I Kaufmann; M Engstner; J Brüggen; W Dippold; D Petzoldt
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 4.  Human tumor-associated antigens identified by monoclonal antibodies.

Authors:  K E Hellström; I Hellström; J P Brown
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies.

Authors:  L Suter; E B Bröcker; J Brüggen; D J Ruiter; C Sorg
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence.

Authors:  T M Rose; G D Plowman; D B Teplow; W J Dreyer; K E Hellström; J P Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines.

Authors:  A Aruffo; M T Dietsch; H Wan; K E Hellström; I Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.

Authors:  A M Gown; A M Vogel; D Hoak; F Gough; M A McNutt
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

9.  Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside.

Authors:  I Hellström; V Brankovan; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

10.  Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

Authors:  S M Larson; J A Carrasquillo; K A Krohn; J P Brown; R W McGuffin; J M Ferens; M M Graham; L D Hill; P L Beaumier; K E Hellström
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.